Coronary thrombolysis with recombinant human tissue-type plasminogen activator. A prospective, randomized, placebocontrolled trial - Collen, D; Topoe, EJ; Tiefenbrunn, AJ; Gold, HK; Weisfeldt, ML; Sobel, BE; Leinbach, RC; Brinker, JA; Ludbrook, PA; Yasuda, T; Bulkley, BH; Robinson, AK; Hutter, AM; Bell, WR; Spadaro, JJ; Khaw, BA; Grossbard, EB (Circulation, 1984)